EP1395253A2 - Behandlung von angstzuständen - Google Patents

Behandlung von angstzuständen

Info

Publication number
EP1395253A2
EP1395253A2 EP01996376A EP01996376A EP1395253A2 EP 1395253 A2 EP1395253 A2 EP 1395253A2 EP 01996376 A EP01996376 A EP 01996376A EP 01996376 A EP01996376 A EP 01996376A EP 1395253 A2 EP1395253 A2 EP 1395253A2
Authority
EP
European Patent Office
Prior art keywords
norepinephrine reuptake
reuptake inhibitor
dsm
tomoxetine
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01996376A
Other languages
English (en)
French (fr)
Inventor
Holly Ann Read
David Michelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of EP1395253A2 publication Critical patent/EP1395253A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
EP01996376A 2000-11-15 2001-11-06 Behandlung von angstzuständen Withdrawn EP1395253A2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24901000P 2000-11-15 2000-11-15
US249010P 2000-11-15
US26536201P 2001-01-31 2001-01-31
US265362P 2001-01-31
PCT/US2001/027801 WO2002040006A2 (en) 2000-11-15 2001-11-06 Treatment of anxiety disorders

Publications (1)

Publication Number Publication Date
EP1395253A2 true EP1395253A2 (de) 2004-03-10

Family

ID=26939750

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01996376A Withdrawn EP1395253A2 (de) 2000-11-15 2001-11-06 Behandlung von angstzuständen

Country Status (16)

Country Link
EP (1) EP1395253A2 (de)
JP (1) JP2004529073A (de)
KR (1) KR20030051812A (de)
CN (1) CN1822825A (de)
AU (1) AU2002217757A1 (de)
BR (1) BR0115301A (de)
CA (1) CA2426069A1 (de)
CZ (1) CZ20031339A3 (de)
EA (1) EA200300567A1 (de)
HR (1) HRP20030384A2 (de)
IL (1) IL155874A0 (de)
MX (1) MXPA03004190A (de)
NO (1) NO20032156D0 (de)
PL (1) PL366119A1 (de)
SK (1) SK5422003A3 (de)
WO (1) WO2002040006A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002070457A1 (en) * 2001-03-06 2002-09-12 Eli Lilly And Company Inhibitor of monoamine uptake
CA2495452A1 (en) * 2002-08-14 2004-02-26 Pharmacia & Upjohn Company Llc Use of reboxetine for the treatment of hot flashes
GB0309440D0 (en) * 2003-04-25 2003-06-04 Lilly Co Eli Quinolone derivatives
WO2004103356A2 (en) * 2003-05-15 2004-12-02 Eli Lilly And Company Treatment of emotional dysregulation
WO2005060949A2 (en) * 2003-12-12 2005-07-07 Eli Lilly And Company Selective norepinephrine reuptake inhibitors for the treatment of hot flashes, impulse control disorders and personality change due to a general medical condition
US8440724B2 (en) 2008-01-09 2013-05-14 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
WO2011056788A2 (en) * 2009-11-03 2011-05-12 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
US20120220665A1 (en) * 2009-11-03 2012-08-30 Mayo Foundation For Medical Education And Research Inhibiting Neurotransmitter Reuptake
US9944618B2 (en) 2013-03-14 2018-04-17 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
EA202192084A1 (ru) * 2019-02-01 2021-10-20 ХОФФМАН ТЕКНОЛОДЖИЗ ЭлЭлСи. Композиции и способы для лечения связанных с тревожностью нарушений

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997041878A1 (en) * 1996-05-07 1997-11-13 Merck & Co., Inc. Treatment of mood disorders with a growth hormone secretagogue
IT1305322B1 (it) * 1998-04-23 2001-05-04 Pharmacia & Upjohn Spa Uso di reboxetina per il trattamento di disturbi nervosi
DE60035232T2 (de) * 1999-07-01 2008-02-14 Pharmacia & Upjohn Co. Llc, Kalamazoo (S,S)-Reboxetin zur Behandlung von chronischem Müdigkeits-Syndrom

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0240006A2 *

Also Published As

Publication number Publication date
AU2002217757A1 (en) 2002-05-27
NO20032156L (no) 2003-05-13
WO2002040006A2 (en) 2002-05-23
MXPA03004190A (es) 2003-09-22
BR0115301A (pt) 2004-12-14
JP2004529073A (ja) 2004-09-24
CA2426069A1 (en) 2002-05-23
HRP20030384A2 (en) 2003-08-31
KR20030051812A (ko) 2003-06-25
EA200300567A1 (ru) 2004-10-28
CN1822825A (zh) 2006-08-23
WO2002040006A3 (en) 2003-12-24
CZ20031339A3 (cs) 2003-10-15
PL366119A1 (en) 2005-01-24
SK5422003A3 (en) 2003-12-02
IL155874A0 (en) 2003-12-23
NO20032156D0 (no) 2003-05-13

Similar Documents

Publication Publication Date Title
US6184222B1 (en) Treatment of conduct disorder
Gillin et al. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial
US6028070A (en) Treatment of oppositional defiant disorder
EA006652B1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
WO2002040006A2 (en) Treatment of anxiety disorders
US20080200555A1 (en) Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
US6683114B2 (en) Treatment of psoriasis
US20040034106A1 (en) Treatment of anxiety disorders
ZA200303738B (en) Treatment of anxiety disorders.
US4443479A (en) Pharmaceutical methods and compositions using parabenzoquinone
US4522830A (en) Pharmaceutical methods using parabenzoquinone to treat muscle spasms
MXPA00002837A (en) Treatment of oppositional defiant disorder
MXPA00002829A (en) Treatment of conduct disorder

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17P Request for examination filed

Effective date: 20040624

17Q First examination report despatched

Effective date: 20040923

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1063438

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050204

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1063438

Country of ref document: HK